Barrier strategies we are implementing center on the creation of molecular barriers to infection. We are developing molecules that adhere to entry sites on mucosal membranes to prevent the absorption of viruses and bacteria into the bloodstream.

		Resources
		Vaccine delivery systems and platform technologies.
		Software development as tools for genetic, genomic and proteomic analysis and modeling of host-pathogen interactions.
		Screening tools and services for high throughput antigen identification.
		Appropriate standardized cell cultures and animal models for antimicrobial vaccine testing and development.
		Validated assays to measure toxicity, safety, efficacy/immunity and other host responses needed for product licensure.